These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 16293227)
1. CHF1/Hey2 suppresses SM-MHC promoter activity through an interaction with GATA-6. Shirvani S; Xiang F; Koibuchi N; Chin MT Biochem Biophys Res Commun; 2006 Jan; 339(1):151-6. PubMed ID: 16293227 [TBL] [Abstract][Full Text] [Related]
2. Transcription factor CHF1/Hey2 regulates neointimal formation in vivo and vascular smooth muscle proliferation and migration in vitro. Sakata Y; Xiang F; Chen Z; Kiriyama Y; Kamei CN; Simon DI; Chin MT Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2069-74. PubMed ID: 15345511 [TBL] [Abstract][Full Text] [Related]
3. Transcription factor CHF1/Hey2 regulates the global transcriptional response to platelet-derived growth factor in vascular smooth muscle cells. Shirvani SM; Mookanamparambil L; Ramoni MF; Chin MT Physiol Genomics; 2007 Jun; 30(1):61-8. PubMed ID: 17327490 [TBL] [Abstract][Full Text] [Related]
4. CHF1/Hey2 plays a pivotal role in left ventricular maturation through suppression of ectopic atrial gene expression. Koibuchi N; Chin MT Circ Res; 2007 Mar; 100(6):850-5. PubMed ID: 17332425 [TBL] [Abstract][Full Text] [Related]
5. Regulation of MMP10 expression by the transcription factor CHF1/Hey2 is mediated by multiple E boxes. Wu L; Chien WM; Hartman ME; Moussavi-Harami F; Liu Y; Chin MT Biochem Biophys Res Commun; 2011 Dec; 415(4):662-8. PubMed ID: 22079635 [TBL] [Abstract][Full Text] [Related]
6. A novel mechanism of transcriptional repression of p27kip1 through Notch/HRT2 signaling in vascular smooth muscle cells. Havrda MC; Johnson MJ; O'Neill CF; Liaw L Thromb Haemost; 2006 Sep; 96(3):361-70. PubMed ID: 16953280 [TBL] [Abstract][Full Text] [Related]
7. The spectrum of cardiovascular anomalies in CHF1/Hey2 deficient mice reveals roles in endocardial cushion, myocardial and vascular maturation. Sakata Y; Koibuchi N; Xiang F; Youngblood JM; Kamei CN; Chin MT J Mol Cell Cardiol; 2006 Feb; 40(2):267-73. PubMed ID: 16242143 [TBL] [Abstract][Full Text] [Related]
8. Hey basic helix-loop-helix transcription factors are repressors of GATA4 and GATA6 and restrict expression of the GATA target gene ANF in fetal hearts. Fischer A; Klattig J; Kneitz B; Diez H; Maier M; Holtmann B; Englert C; Gessler M Mol Cell Biol; 2005 Oct; 25(20):8960-70. PubMed ID: 16199874 [TBL] [Abstract][Full Text] [Related]
9. Hypoxia-mediated activation of Dll4-Notch-Hey2 signaling in endothelial progenitor cells and adoption of arterial cell fate. Diez H; Fischer A; Winkler A; Hu CJ; Hatzopoulos AK; Breier G; Gessler M Exp Cell Res; 2007 Jan; 313(1):1-9. PubMed ID: 17045587 [TBL] [Abstract][Full Text] [Related]
10. Activation of the beta myosin heavy chain promoter by MEF-2D, MyoD, p300, and the calcineurin/NFATc1 pathway. Meissner JD; Umeda PK; Chang KC; Gros G; Scheibe RJ J Cell Physiol; 2007 Apr; 211(1):138-48. PubMed ID: 17111365 [TBL] [Abstract][Full Text] [Related]
11. Calcineurin-GATA-6 pathway is involved in smooth muscle-specific transcription. Wada H; Hasegawa K; Morimoto T; Kakita T; Yanazume T; Abe M; Sasayama S J Cell Biol; 2002 Mar; 156(6):983-91. PubMed ID: 11889139 [TBL] [Abstract][Full Text] [Related]
13. Transcription factor CHF1/Hey2 suppresses cardiac hypertrophy through an inhibitory interaction with GATA4. Xiang F; Sakata Y; Cui L; Youngblood JM; Nakagami H; Liao JK; Liao R; Chin MT Am J Physiol Heart Circ Physiol; 2006 May; 290(5):H1997-2006. PubMed ID: 16603706 [TBL] [Abstract][Full Text] [Related]
14. A p300 protein as a coactivator of GATA-6 in the transcription of the smooth muscle-myosin heavy chain gene. Wada H; Hasegawa K; Morimoto T; Kakita T; Yanazume T; Sasayama S J Biol Chem; 2000 Aug; 275(33):25330-5. PubMed ID: 10851229 [TBL] [Abstract][Full Text] [Related]
15. Statins activate GATA-6 and induce differentiated vascular smooth muscle cells. Wada H; Abe M; Ono K; Morimoto T; Kawamura T; Takaya T; Satoh N; Fujita M; Kita T; Shimatsu A; Hasegawa K Biochem Biophys Res Commun; 2008 Oct; 374(4):731-6. PubMed ID: 18671946 [TBL] [Abstract][Full Text] [Related]
16. CHF1/Hey2 promotes physiological hypertrophy in response to pressure overload through selective repression and activation of specific transcriptional pathways. Yu M; Liu Y; Xiang F; Li Y; Cullen D; Liao R; Beyer RP; Bammler TK; Chin MT OMICS; 2009 Dec; 13(6):501-11. PubMed ID: 20001863 [TBL] [Abstract][Full Text] [Related]
17. Transcriptional repression by the basic helix-loop-helix protein Dec2: multiple mechanisms through E-box elements. Fujimoto K; Hamaguchi H; Hashiba T; Nakamura T; Kawamoto T; Sato F; Noshiro M; Bhawal UK; Suardita K; Kato Y Int J Mol Med; 2007 Jun; 19(6):925-32. PubMed ID: 17487425 [TBL] [Abstract][Full Text] [Related]
18. Myocardial deletion of transcription factor CHF1/Hey2 results in altered myocyte action potential and mild conduction system expansion but does not alter conduction system function or promote spontaneous arrhythmias. Hartman ME; Liu Y; Zhu WZ; Chien WM; Weldy CS; Fishman GI; Laflamme MA; Chin MT FASEB J; 2014 Jul; 28(7):3007-15. PubMed ID: 24687990 [TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of the NADPH oxidase isoform, Nox1, in colon epithelial cells: role of GATA-binding factor(s). Brewer AC; Sparks EC; Shah AM Free Radic Biol Med; 2006 Jan; 40(2):260-74. PubMed ID: 16413408 [TBL] [Abstract][Full Text] [Related]